Table 1.
Drug A | Drug B | |
---|---|---|
1. | Amphetamine & Derivatives | MAOIs |
2. | Atazanavir | PPIs |
3. | Febuxostat | Azathioprine & Mercaptopurine |
4. | SSRIs | MAOIs |
5. | Irinotecan | Strong CYP3A4 Inhibitors |
6. | Narcotic Analgesics | MAOIsa |
7. | Tricyclic Antidepressants | MAOIs |
8. | High-risk QT Prolonging Agents | High-risk QT Prolonging Agents |
9. | Ramelteon | Strong CYP1A2 Inhibitors |
10. | Strong CYP3A4 Inducers | Protease Inhibitors |
11. | HMG Co-A Reductase Inhibitors | CYP3A4 & Protease Inhibitors |
12. | CYP3A4 & Protease Inhibitors | Ergot Alkaloids & Derivatives |
13. | Tizanidine | CYP1A2 Inhibitors |
14. | Tranylcypromine | Procarbazine |
15. | Triptans | MAOIs |
Abbreviations: MAOI, monoamine oxidase inhibitor; SSRI, selective serotonin reuptake inhibitor; CYP3A4, cytochrome P450 isozyme 3A4; CYP1A2, cytochrome P450 isozyme 1A2; PPI, proton pump inhibitor.